There are still some intractable neurological disorders with unknown causes that have a progressive clinical course. It is important to develop treatments for such neurological disorders. The Japanese Society of Neurological Therapeutics (JSNT) was established in 1983 for this very reason.
There has been substantial progress in the treatment of neurological disorders, such as stroke, Parkinson's disease, Alzheimer's disease, neuroimmunological diseases, migraine, epilepsy, and so on, using not only drug therapy, but also gene therapy, tissue engineering, nerve stimulation and rehabilitation. In order to develop treatments for neurological disorders, the individual activities of JSNT are also important.
JSNT is involved in exchanges with the American Society for Experimental NeuroTherapeutics (ASENT) in the USA. The mission of ASENT is to facilitate cooperation between academia, government, industry, the clinical community and advocacy groups to enable and advance the discovery, translation, and development of neurotherapeutics. Through communication with ASENT, the importance of information exchange and cooperation between these parties has been further recognized. To further the development of new treatments for neurological diseases, JSNT is communicating with the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan through an active exchange of views. The PMDA is also serving as a consultant on drug strategy in JSNT meetings. JSNT has examined unmet medical needs for neurological diseases through collaboration with ASENT. JSNT has studied the current status of treatment for essential tremor in Japan and has clarified the characteristics and differences of essential tremor under practical medical conditions between Japan and foreign countries.
Education for young doctors and co–medical staff and lifelong education about the treatment of neurological disorders are also important. JSNT is preparing some educational programs and has published some practice parameters and guidelines for the treatment of neurological disorders.
In JSNT, we will have the online–only journal publishing high quality peer reviewed articles related to treatment of neurological disorders. Now, we will plan to obtain the legal personality of JSNT, in order to work more active operations.
Thus, JSNT is contributing to progress in the treatment of neurological disorders.
抄録全体を表示